Stock Earnings

Question 1

What are Neuraxis Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Neuraxis Inc has a total asset of $4, Net loss of $-8

Question 2

What are the key financial ratios for NRXS?

Accepted Answer

Neuraxis Inc's Current ratio is 2, has a Net margin is -400, sales per share of $0.28.

Question 3

How is Neuraxis Inc's revenue broken down by segment or geography?

Accepted Answer

Neuraxis Inc largest revenue segment is Medical Neuromodulation Devices, at a revenue of 2,460,049 in the most earnings release.For geography, United States is the primary market for Neuraxis Inc, at a revenue of 2,460,049.

Question 4

Is Neuraxis Inc profitable?

Accepted Answer

no, according to the latest financial statements, Neuraxis Inc has a net loss of $-8

Question 5

Does Neuraxis Inc have any liabilities?

Accepted Answer

yes, Neuraxis Inc has liability of 2

Question 6

How many outstanding shares for Neuraxis Inc?

Accepted Answer

Neuraxis Inc has a total outstanding shares of 6.99

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	3	2	2	2	2	1
Revenue Growth (YoY)	50%	0%	0%	0%	100%	--
Cost of Revenue	0	0	0	0	0	0
Gross Profit	2	2	2	2	2	1
Selling, General & Admin	9	9	8	5	5	5
Research & Development	0	0	0	0	0	0
Operating Expenses	9	9	8	5	5	5
Other Non Operating Income (Expenses)	0	0	-4	0	0	0
Pretax Income	-7	-8	-14	-4	-3	-3
Income Tax Expense	--	--	--	--	--	--
Net Income	-7	-8	-14	-5	-3	-4
Net Income Growth	-53%	-43%	180%	67%	-25%	--
Shares Outstanding (Diluted)	8.52	6.91	3.25	6.11	6.11	6.11
Shares Change (YoY)	23%	112.99%	-47%	0%	0%	--
EPS (Diluted)	-0.91	-1.22	-4.49	-0.91	-0.62	-0.71
EPS Growth	-59%	-73%	394%	47%	-13%	--
Free Cash Flow	-6	-6	-6	-2	-2	-4
Free Cash Flow Per Share	-0.7	-0.86	-1.84	-0.32	-0.32	-0.65
Gross Margin	66.66%	100%	100%	100%	100%	100%
Operating Margin	-233.33%	-350%	-300%	-150%	-100%	-400%
Profit Margin	-233.33%	-400%	-700%	-250%	-150%	-400%
Free Cash Flow Margin	-200%	-300%	-300%	-100%	-100%	-400%
EBITDA	-7	-7	-6	-3	-2	-4
EBITDA Margin	-233.33%	-350%	-300%	-150%	-100%	-400%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-7	-7	-6	-3	-2	-4
EBIT Margin	-233.33%	-350%	-300%	-150%	-100%	-400%
Effective Tax Rate	--	--	--	--	--	--

Neuraxis Inc (NRXS) Price

NRXS Stock Price Chart

NRXS Income

Follow-Up Questions